NCT04545632View on ClinicalTrials.gov

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor

CompletedOBSERVATIONAL
Enrollment

458

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

February 26, 2021

Study Completion Date

June 24, 2021

Conditions
Breast CancerNSCLCProstate CancerHead and Neck CancerGastric CancerEsophageal CancerOvarian Cancer
Trial Locations (1)

Unknown

Hanyang University Guri Hospital, Guri-si

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT04545632 - Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor | Biotech Hunter | Biotech Hunter